Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026850 (
muscular dystrophy
)
5,870
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It has been proposed that
aquaporin-4
(
AQP4
), a water channel expressed at the plasmalemma of skeletal muscle cells, is important in normal muscle physiology and in the pathophysiology of Duchenne's
muscular dystrophy
. To test this hypothesis, muscle water permeability and function were compared in wild-type and
AQP4
knockout mice. Immunofluorescence and freeze-fracture electron microscopy showed
AQP4
protein expression in plasmalemma of fast-twitch skeletal muscle fibers of wild-type mice. Osmotic water permeability was measured in microdissected muscle fibers from the extensor digitorum longus (EDL) and fractionated membrane vesicles from EDL homogenates. With the use of spatial-filtering microscopy to measure osmotically induced volume changes in EDL fibers, half times (t(1/2)) for osmotic equilibration (7.5-8.5 s) were not affected by
AQP4
deletion. Stopped-flow light-scattering measurements of osmotically induced volume changes in plasmalemma vesicles also showed no significant differences in water permeability. Similar water permeability, yet approximately 90% decreased
AQP4
protein expression was found in EDL from mdx mice that lack dystrophin. Skeletal muscle function was measured by force generation in isolated EDL, treadmill performance time, and in vivo muscle swelling in response to water intoxication. No differences were found in EDL force generation after electrical stimulation [42 +/- 2 (wild-type) vs. 41 +/- 2 (knockout) g/s], treadmill performance time (22 vs. 26 min; 29 m/min, 13 degrees incline), or muscle swelling (2.8 vs. 2.9% increased water content at 90 min after intraperitoneal water infusion). Together these results provide evidence against a significant role of
AQP4
in skeletal muscle physiology in mice.
...
PMID:Skeletal muscle function and water permeability in aquaporin-4 deficient mice. 1083 38
Duchenne Muscular Dystrophy (DMD) is a progressive lethal muscle disease that affects young boys. Dystrophin, absent in DMD and reduced in the milder form Becker Muscular Dystrophy (BMD), binds to several membrane-associated proteins known as dystrophin-associated proteins (DAPs). Once this critical structural link is disrupted, muscle fibers become more vulnerable to mechanical and osmotic stress. Recently, we have reported that the expression of
aquaporin-4
(
AQP4
), a water-selective channel expressed in the sarcolemma of fast-twitch fibers and astrocyte end-feet, is drastically reduced in the muscle and brain of the mdx mouse, the animal model of DMD. In the present study, we analyzed the expression of
AQP4
in several DMD/BMD patients of different ages with different mutations in the dystrophin gene. Immunofluorescence results indicate that, compared with healthy control children,
AQP4
is reduced severely in all the DMD muscular biopsies analyzed and in 50% of the analyzed BMD. Western blot analysis revealed that the deficiency in sarcolemma
AQP4
staining is due to a reduction in total
AQP4
muscle protein content rather than to changes in immunoreactivity. Double-immunostaining experiments indicate that
AQP4
reduction is independent of changes in the fiber myosin heavy chain composition.
AQP4
and a-syntrophin analysis of BMD muscular biopsies revealed that the expression and stability of
AQP4
in the sarcolemma does not always decrease when a-syntrophin is strongly reduced. Finally, limb-girdle muscular dystrophy biopsies and facioscapulohumeral muscular dystrophy revealed that
AQP4
expression was not altered in these forms of
muscular dystrophy
. These experiments provide the first evidence of
AQP4
reduction in a human pathology and show that this deficiency is an important feature of DMD/BMD.
...
PMID:Altered aquaporin-4 expression in human muscular dystrophies: a common feature? 1203 47
Aquaporins are a growing family of transmembrane proteins that transport water and, in some cases, glycerol and urea across cellular membranes.
Aquaporin-4
(
AQP4
) is enriched at the sarcolemma of skeletal muscle and may play a role in accommodating the rapid changes in cell volume and hydrostatic forces that occur during contraction in order to prevent damage to the sarcolemma. Recent evidence has shown that
AQP4
is absent in dystrophin-deficient mdx mice, suggesting that
AQP4
associates with dystrophin and has a role in the dystrophic process. To examine the relationship between aquaporins and muscle disease, and between aquaporins and dystrophin, we have investigated aquaporin expression in various mouse models of
muscular dystrophy
and cardiomyopathy before and after the onset of pathology. We find that
AQP4
is expressed in prenecrotic mdx muscle despite the absence of dystrophin and that
AQP4
is lost after the onset of muscle degeneration. Analysis of various dystrophin transgenic mice reveals that
AQP4
is lost even when the dystrophin-glycoprotein complex is present, suggesting that loss of
AQP4
is not directly resulting from loss of the DGC.
AQP4
was also lost in muscular dystrophies caused by primary mutations in the sarcoglycan genes. Taken together, our data demonstrate that
AQP4
loss in skeletal muscle correlates with
muscular dystrophy
and is a common feature of pathogenesis.
...
PMID:Characterization of aquaporin-4 in muscle and muscular dystrophy. 1208 55
alpha-Dystrobrevin associates with and is a homologue of dystrophin, the protein linked to Duchenne and Becker muscular dystrophies. We used a transgenic approach to restore alpha-dystrobrevin to the sarcolemma in mice that lack dystrophin (mdx mice) to study two interrelated functions: (1) the ability of alpha-dystrobrevin to rescue components of the dystrophin complex in the absence of dystrophin and (2) the ability of sarcolemmal alpha-dystrobrevin to ameliorate the dystrophic phenotype. We generated transgenic mice expressing alpha-dystrobrevin-2a linked to a palmitoylation signal sequence and bred them onto the alpha-dystrobrevin-null and mdx backgrounds. Expression of palmitoylated alpha-dystrobrevin prevented the
muscular dystrophy
observed in the alpha-dystrobrevin-null mice, demonstrating that the altered form of alpha-dystrobrevin was functional. On the mdx background, the palmitoylated form of alpha-dystrobrevin was expressed on the sarcolemma but did not significantly ameliorate the
muscular dystrophy
phenotype. Palmitoylated dystrobrevin restored alpha-syntrophin and
aquaporin-4
(
AQP4
) to the mdx sarcolemma but was unable to recruit beta-dystroglycan or the sarcoglycans. Despite restoration of sarcolemmal alpha-syntrophin, neuronal nitric oxide synthase (nNOS) was not localized to the sarcolemma, suggesting that nNOS requires both dystrophin and alpha-syntrophin for correct localization. Thus, although nNOS and
AQP4
both require interaction with the PDZ domain of alpha-syntrophin for sarcolemmal association, their localization is regulated differentially.
...
PMID:Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed alpha-dystrobrevin. 1805 22
Altered
aquaporin-4
(
AQP4
) expression has been reported in brain edema, tumors,
muscular dystrophy
, and neuromyelitis optica. However, the plasma membrane organization of
AQP4
and its interaction with proteins such as the dystrophin-associated protein complex are not well understood. In this study, we used sucrose density gradient ultracentrifugation and 2D blue native/sodium dodecyl sulfate-polyacrylamide gel electrophoresis and showed the expression of several
AQP4
multi-subunit complexes (pools) of different sizes, ranging from >> 1 MDa to approximately 500 kDa and containing different ratios of the 30/32 kDa
AQP4
isoforms, indicative of orthogonal arrays of particles of various sizes. A high molecular weight pool co-purified with dystrophin and beta-dystroglycan and was drastically reduced in the skeletal muscle of mdx3cv mice, which have no dystrophin. The number and size of the
AQP4
pools were the same in the kidney where dystrophin is not expressed, suggesting the presence of dystrophin-like proteins for their expression. We found that AQP2 is expressed only in one major pool of approximately 500 kDa, indicating that the presence of different pools is a peculiarity of
AQP4
rather than a widespread feature in the AQP family. Finally, in skeletal muscle caveolin-3 did not co-purify with any
AQP4
pool, indicating the absence of interaction of the two proteins and confirming that caveolae and orthogonal arrays of particles are two independent plasma membrane microdomains. These results contribute to a better understanding of
AQP4
membrane organization and raise the possibility that abnormal expression of specific
AQP4
pools may be found in pathological states.
...
PMID:Expression of multiple AQP4 pools in the plasma membrane and their association with the dystrophin complex. 1828 10
Aquaporin-4
(
AQP4
) is the major water channel expressed in fast-twitch skeletal muscle fibers.
AQP4
is reduced in Duchenne and Becker
Muscular Dystrophies
, but not in caveolinopathies, thus suggesting an interaction with dystrophin or with members of the dystrophin-glycoprotein complex (DGC) rather than a nonspecific effect due to muscle membrane damage. To establish the role of sarcoglycans in
AQP4
decrease occurring in
muscular dystrophy
,
AQP4
expression was analyzed in muscle biopsies from patients affected by Limb Girdle Muscular Dystrophies (LGMDs) 2C-F genetically confirmed. In all the LGMD 2C-F (2alpha-, 1beta-, 2gamma-, 1delta-deficiency),
AQP4
was severely decreased. This effect was associated to a marked reduction in alpha1-syntrophin levels. In control muscle
AQP4
did not show a direct interaction with any of the four sarcoglycans but, it co-immunoprecipitated with alpha1-syntrophin, indicating that this modular protein may link
AQP4
levels with the DGC complex. To determine whether
AQP4
expression could be affected in other LGMDs due to the defect of a membrane protein not associated to the dystrophin complex, we examined
AQP4
expression in 6 patients affected by dysferlin deficiency genetically confirmed. All the patients displayed a reduction of the water channel, and
AQP4
expression appeared to correlate with the severity of the muscle histopathological lesions. However, differently from what observed in the sarcoglycans, alpha1-syntrophin expression was normal or just slightly reduced. These results seem to indicate an additional mechanism of regulation of
AQP4
levels in muscle cells. In accordance with a specific effect of membrane muscle disorders,
AQP4
protein levels were not changed in 3 mitochondrial and 3 metabolic myopathies. In conclusion,
AQP4
expression and membrane localization are markedly reduced in LGMD 2B-2F. The role of
AQP4
in the degenerative mechanism occurring in these diseases will be the object of our future research.
...
PMID:Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies. 1864 58